Concord Biotech Ltd.

₹1141

- 15.80 (-1.37%)

09:22 am - close price

BSE: CONCORDBIO

NSE: CONCORDBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 35.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 6.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 22.26Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.02Good: 0.5

✅

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 35.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 6.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 22.26Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.02Good: 0.5

✅

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	194.83	262.35	240.80	318.97	215.80
Expenditure+	122.68	143.16	134.87	184.68	134.52
Other Income+	6.65	8.13	8.19	10.81	10.31
Operating Profit	72.15	119.19	105.93	134.29	81.28
Interest	0.75	0.84	0.49	0.46	0.24
Depreciation and Amortization	13.04	13.29	13.54	13.72	13.18
Profit Before Tax	71.04	109.70	103.10	128.72	79.52
Tax+	16.54	28.69	25.53	33.70	19.93
Net Profit	54.49	81.02	77.57	95.02	59.59

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6169.43	7129.33	85316.82	101693.92	120008.69
Operational Expenses+	2890.11	4390.08	50458.93	58475.00	69324.30
Operating Profit	3279.32	2739.25	34857.89	43218.92	50684.39
Other Income	138.07	234.16	3530.93	3378.00	4444.67
OPM %	53.15	38.42	40.86	42.50	42.23
Depreciation and Amortisation	275.23	500.50	5403.24	5359.15	5437.35
Interest	10.47	61.35	980.17	318.40	104.17
Profit Before Tax	3127.20	2375.18	32201.34	41256.50	49455.33
Tax	780.59	621.95	8191.16	10446.18	12291.10
Net Profit	2348.45	1749.29	24008.57	30810.32	37164.23

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	13127.36	15018.69	151398.18	170070.85	203425.15
Liabilities+	13127.36	15018.69	151398.18	170070.85	203425.15

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1668.17	2074.75	24600.18	26546.71	24451.69
Cash from Investing Activity	-1952.05	-1117.88	-15795.01	-15460.93	-15998.65
Cash from Financing Activity	311.24	-1001.64	-8521.94	-9921.49	-9876.80
Net Cash Flow	27.36	-44.77	283.23	1164.29	-1423.76
Opening Cash & Cash Equivalents	24.08	51.44	66.69	349.92	1514.21
Closing Cash & Cash Equivalents	51.44	6.67	349.92	1514.21	90.45

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08
Public+	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	81815	82650	82045	81219	82004	84298	80737	83296	87486	100927

Corporate Actions

132 events in the last 3 years

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	13127.36	15018.69	151398.18	170070.85	203425.15
Liabilities+	13127.36	15018.69	151398.18	170070.85	203425.15

Ratios

Reported EPS

Bad: 2Current: 35.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 6.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 22.26Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.02Good: 0.5

✅

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 35.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 29.62Good: 20

✅

Current Ratio

Bad: 1Current: 6.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 22.26Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.02Good: 0.5

✅

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	1668.17	2074.75	24600.18	26546.71	24451.69
Cash from Investing Activity	-1952.05	-1117.88	-15795.01	-15460.93	-15998.65
Cash from Financing Activity	311.24	-1001.64	-8521.94	-9921.49	-9876.80
Net Cash Flow	27.36	-44.77	283.23	1164.29	-1423.76
Opening Cash & Cash Equivalents	24.08	51.44	66.69	349.92	1514.21
Closing Cash & Cash Equivalents	51.44	6.67	349.92	1514.21	90.45

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	194.83	262.35	240.80	318.97	215.80
Expenditure+	122.68	143.16	134.87	184.68	134.52
Other Income+	6.65	8.13	8.19	10.81	10.31
Operating Profit	72.15	119.19	105.93	134.29	81.28
Interest	0.75	0.84	0.49	0.46	0.24
Depreciation and Amortization	13.04	13.29	13.54	13.72	13.18
Profit Before Tax	71.04	109.70	103.10	128.72	79.52
Tax+	16.54	28.69	25.53	33.70	19.93
Net Profit	54.49	81.02	77.57	95.02	59.59

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	6169.43	7129.33	85316.82	101693.92	120008.69
Operational Expenses+	2890.11	4390.08	50458.93	58475.00	69324.30
Operating Profit	3279.32	2739.25	34857.89	43218.92	50684.39
Other Income	138.07	234.16	3530.93	3378.00	4444.67
OPM %	53.15	38.42	40.86	42.50	42.23
Depreciation and Amortisation	275.23	500.50	5403.24	5359.15	5437.35
Interest	10.47	61.35	980.17	318.40	104.17
Profit Before Tax	3127.20	2375.18	32201.34	41256.50	49455.33
Tax	780.59	621.95	8191.16	10446.18	12291.10
Net Profit	2348.45	1749.29	24008.57	30810.32	37164.23

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Concord Biotech Ltd.

₹1141

- 15.80 (-1.37%)

09:22 am - close price

BSE: CONCORDBIO

NSE: CONCORDBIO

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08
Public+	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92	55.92
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	81815	82650	82045	81219	82004	84298	80737	83296	87486	100927

Corporate Actions

132 events in the last 3 years